Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ADCs in gynaecological cancers

The new challenge: ADC class effects, on/off-target adverse reactions and their interdisciplinary management

Date

23 Feb 2023

Session

ADCs in gynaecological cancers

Topics

Supportive Care and Symptom Management;  Cytotoxic Therapy;  Targeted Therapy;  Immunotherapy

Tumour Site

Ovarian Cancer;  Endometrial Cancer;  Cervical Cancer

Presenters

Toon Van Gorp

Authors

T. Van Gorp

Author affiliations

  • University Hospitals Leuven - Campus Gasthuisberg, Leuven/BE

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.